Feasibility Study of an Automated Point-of-Care Urine Diagnostic Device for Pregnancy
- Conditions
- Pregnancy Related
- Interventions
- Diagnostic Test: Pregnancy test
- Registration Number
- NCT03575286
- Lead Sponsor
- Voyant Diagnostics, Inc.
- Brief Summary
The primary purpose of this observational study is to demonstrate the feasibility of an automated point-of-care urine diagnostic device in determining the pregnancy status of patients through urine samples collected from patients at Northwestern University. Our hypothesis is that this automated point-of-care urine diagnostic device will be able to accurately determine a patient's pregnancy status at least 95% of the time.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 123
- Patient age 18 years and older, upper age limit of 45 years
- Female patient
- Patients undergoing any procedures for pregnancy diagnosis and confirmation
- English speaking
The following special population will be included:
- Pregnant women
- Adults unable to consent
- Individuals who are not yet adults (infants, children, and teenagers)
- Prisoners
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Non-pregnant female Pregnancy test Patient has been determined not pregnant with a urine pregnancy test and, if applicable, a serum pregnancy test performed at Northwestern University. Pregnant female Pregnancy test Patient has been determined pregnant with a urine pregnancy test and, if applicable, a serum pregnancy test performed at Northwestern University.
- Primary Outcome Measures
Name Time Method Accuracy in determining pregnancy status Time of collection - 1 month post collection Compare qualitative pregnancy test results generated by Voyant's device with urine pregnancy test result(s) and, if applicable, serum pregnancy test results performed at Northwestern University. From this comparison, we will determine the accuracy of Voyant's device. We will be using the same urine sample used at Northwestern.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Northwestern University
🇺🇸Chicago, Illinois, United States